Cargando…
Diquafosol tetrasodium elicits total cholesterol release from rabbit meibomian gland cells via P2Y(2) purinergic receptor signalling
Diquafosol tetrasodium (DQS), a purinergic P2Y(2) receptor agonist, stimulates secretion of both water and mucins from the conjunctiva into tears. Hence, DQS-containing eye drops have been approved as a therapeutic option for dry eye disease in some Asian countries, including Japan. Recent clinical...
Autores principales: | Endo, Ken-ichi, Sakamoto, Asuka, Fujisawa, Koushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997929/ https://www.ncbi.nlm.nih.gov/pubmed/33772064 http://dx.doi.org/10.1038/s41598-021-86433-6 |
Ejemplares similares
Cargando…
Hyperglycemia Induces Meibomian Gland Dysfunction
por: Guo, Yuli, et al.
Publicado: (2022)
por: Guo, Yuli, et al.
Publicado: (2022)
Ejemplares similares
-
Topical diquafosol for patients with obstructive meibomian gland dysfunction
por: Arita, Reiko, et al.
Publicado: (2013) -
Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
por: Amano, Shiro, et al.
Publicado: (2017) -
Comparison of cytotoxicities and wound healing effects of diquafosol tetrasodium and hyaluronic acid on human corneal epithelial cells
por: Lee, Jong Heon, et al.
Publicado: (2017) -
Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study
por: Fukuoka, Shima, et al.
Publicado: (2019) -
The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
por: Guo, Yue, et al.
Publicado: (2020)